{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:17:27Z","timestamp":1753355847939},"reference-count":39,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1016\/s0959-8049(97)00240-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:45:37Z","timestamp":1027619137000},"page":"2246-2251","source":"Crossref","is-referenced-by-count":24,"title":["Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (il-6), interleukin-l\u03b2 (IL-I\u03b2), interleukin-11 (IL-11) and tumour necrosis factor-\u03b1 (TNF-\u03b1) in p53-characterised human ovarian carcinomas"],"prefix":"10.1016","volume":"33","author":[{"given":"J.G.W.","family":"Asschert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vellenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hollema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.J.","family":"Van Der Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.G.E.","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/S0959-8049(97)00240-2_BIB1","first-page":"545","article-title":"Growth regulation and transformation of ovarian epithelium","volume":"71","author":"1.Berchuck","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00001622-199309000-00020","article-title":"The biology of ovarian cancer","volume":"5","author":"Boente","year":"1993","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB3","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L","article-title":"Serum and ascitic fluid levels ofinterleukin-1, interleuldn-6, and tumour necrosis factor-alpha in patients with ovarian epithelial cancer","volume":"72","author":"Moradi","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/excr.1993.1200","article-title":"Constitutive production of macrophage colony-stimulating factor and interleuldn-6 by human ovarian surface epithelial cells","volume":"207","author":"Lidor","year":"1993","journal-title":"Exp Cell Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB5","first-page":"2248","article-title":"Human ovarian epithelial cancer cells cultured in vitro express both interleukin-l\u03b1 and \u03b2 genes","volume":"52","author":"Li","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB6","first-page":"3139","article-title":"Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines","volume":"53","author":"Guillaume","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB7","first-page":"1939","article-title":"Tumour necrosis factor \u03b1 as an autocrine and paracrine growth factor for ovarian cancer: Monokine induction of tumour cell proliferation and tumour necrosis factor \u03b1 expression","volume":"53","author":"Wu","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB8","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI116446","article-title":"Tumour necrosis factor and its receptors in human ovarian cancer: Potential role in disease progression","volume":"91","author":"Naylor","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB9","first-page":"333","article-title":"The macrophage colony stimulating factor CSF-1 is produced by human ovarian and endometrial adenocarcinoma-derived cell lines and is present at abnormally high levels in the plasma of ovarian carcinoma patients with active disease","volume":"7","author":"Kacinsky","year":"1989"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0002-9378(12)90761-9","article-title":"Increased serum levels of macrophage colony stimulating factor in ovarian cancer","volume":"165","author":"Xu","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9378(92)91846-3","article-title":"Serum levels of macrophage colony-stimulating factor in ovarian cancer patients undergoing second look laparotomy","volume":"166","author":"Elg","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(91)90582-C","article-title":"Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer","volume":"164","author":"Berek","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/1097-0142(19950215)75:4<1004::AID-CNCR2820750416>3.0.CO;2-G","article-title":"Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumours correlate with decreased hemoglobin levels and increased platelet counts","volume":"75","author":"Van der Zee","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9378(93)90485-2","article-title":"Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival","volume":"168","author":"Price","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0002-9378(92)91379-O","article-title":"Stimulation of ovarian tumour cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumour necrosis factor-\u03b1","volume":"166","author":"Wu","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB16","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.151.5.2555","article-title":"Involvement of IL-6 transducer gp 130 in IL-11-mediated signal transducrion","volume":"151","author":"Yin","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB17","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.V83.8.2023.2023","article-title":"Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment","volume":"83","author":"Du","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB18","first-page":"2979","article-title":"Overexpression and mutation of p53 in epithelial ovarian cancer","volume":"51","author":"Marks","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB19","first-page":"643","article-title":"Mutation and overexpression of p53 in early-stage epithelial ovarian cancer","volume":"81","author":"Kohler","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1995.13.1.70","article-title":"The value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2 and p53 as prognostic factors in ovarian carcinomas","volume":"13","author":"Van der Zee","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB21","first-page":"7605","article-title":"Repression of the IL-6 gene promoter by p53 and the RB susceptible gene product","volume":"88","author":"Santhanam","year":"1991"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB22","doi-asserted-by":"crossref","first-page":"15096","DOI":"10.1016\/S0021-9258(18)82442-5","article-title":"Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C\/EBP\u03b2 (NF-IL-6) activity by p53 species","volume":"268","author":"Margulies","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB23","first-page":"17","author":"Serov","year":"1973"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB24","first-page":"567","article-title":"Importance of histological grade in the prognosis of epithelial ovarian carcinomas","volume":"59","author":"Sobre","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1432-1033.1986.tb09919.x","article-title":"Isolation ofhuman-p53-specific monoclonal antibodies and their use in the studies of human p53 expression","volume":"159","author":"Banks","year":"1986","journal-title":"Eur J Biochem"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB26","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood.V71.6.1529.1529","article-title":"Independent regulation of the M-CSF and G-CSF gene expression in human monocytes","volume":"71","author":"Vellenga","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB27","first-page":"7.49","author":"Maniatis","year":"1982"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0003-2697(83)90418-9","article-title":"A technique for radiolabeling DNA restriction endonuclease fragments of high specific activity","volume":"132","author":"Feinberg","year":"1983","journal-title":"Anal Biochem"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB29","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.4049\/jimmunol.139.12.4116","article-title":"Molecular cloning and expression of hybridoma growth factor in E. coli","volume":"139","author":"Brakenhoff","year":"1987","journal-title":"J Immunoi"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB30","first-page":"6959","article-title":"Constitutive production of interleukin 6 by ovarian cancer cell lines and by ovarian tumour cultures","volume":"50","author":"Watson","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB31","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/S0021-9258(17)41763-7","article-title":"G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-l\u03b2 and interleukin-6 expression in human monocytes","volume":"269","author":"Dokter","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB32","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/MCB.5.10.2851","article-title":"p53 cellular tumour antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumours","volume":"5","author":"Rogel","year":"1985","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB33","first-page":"705","article-title":"The p53 tumour suppressor gene","volume":"342","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1242\/jcs.101.1.183","article-title":"Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli","volume":"101","author":"Midgley","year":"1992","journal-title":"J Cell Sci"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB35","first-page":"4196","article-title":"Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines","volume":"52","author":"Yaginuma","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB36","first-page":"8145","article-title":"The p50 subunit of NF-\u03baB associates with the NF-IL6 transcription factor","volume":"89","author":"Le Clair","year":"1992"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB37","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood.V78.8.1988.1988","article-title":"Involvement of a nuclear factor-\u03baB-like protein in induction of the macrophage colonystimulating factor gene by tumour necrosis factor","volume":"78","author":"Yamada","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0142(19930801)72:3<809::AID-CNCR2820720329>3.0.CO;2-5","article-title":"Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha","volume":"72","author":"Mizutani","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(97)00240-2_BIB39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<725::AID-CNCR19>3.0.CO;2-2","article-title":"Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-\u03b1 and cis-diamminedichloroplatinum","volume":"77","author":"Uslu","year":"1996","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804997002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804997002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T09:07:22Z","timestamp":1681204042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804997002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0959804997002402"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(97)00240-2","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}